Primrose’s unique and broad capabilities in nucleic acid engineering ... from small-interfering RNA and other oligonucleotides to peptide- and protein-based therapies, depend on high-quality ...

More information: Sungho Kim et al, Fast and accurate multi-bacterial identification using cleavable and FRET-based peptide nucleic acid probes, Biosensors and Bioelectronics (2024). DOI ...

Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the governments of Canada and Alberta for an R&D facility.